XML 89 R41.htm IDEA: XBRL DOCUMENT
v2.4.0.8

17. Parent Company Financial Statements (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2013
Condensed Financial Information of Parent Company Only Disclosure [Abstract] |
Parent Balance Sheets | Aemetis, Inc. (Parent Company) Consolidated Balance Sheets As of December 31, 2013 and 2012
Assets |  | 2013 |  |  | 2012 |  |  |
Current assets |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 13,718 |  |  | $ | - |  |  |
Intercompany receivables |  |  | 27,627,159 |  |  |  | 20,802,877 |  |  |
Total current assets |  |  | 27,640,877 |  |  |  | 20,802,877 |  |  |
Investments in Subsidiaries, net of advances |  |  |  |  |  |  |  |  |  |
Investment in Aemetis International, Inc. |  |  | 2,678,525 |  |  |  | 3,060,684 |  |  |
Investment in Aemetis Americas, Inc |  |  | - |  |  |  | 116,144 |  |  |
Total investments in Subsidiaries, net of advances |  |  | 2,678,525 |  |  |  | 3,176,828 |  |  |
Other assets |  |  | 23,095 |  |  |  | 23,095 |  |  |
Total Assets |  | $ | 30,342,497 |  |  | $ | 24,002,800 |  |  |
Liabilities & stockholders' equity(deficit) |  |  |  |  |  |  |  |  |  |
Current liabilities |  |  |  |  |  |  |  |  |  |
Accounts payable |  | $ | 3,397,294 |  |  | $ | 4,037,137 |  |  |
Outstanding checks in excess of cash |  |  | - |  |  |  | 25,773 |  |  |
Mandatorily redeemable Series B convertibe preferred |  |  | 2,539,528 |  |  |  | 2,437,649 |  |  |
Other current liabilities |  |  | 1,677,835 |  |  |  | 2,174,608 |  |  |
Total current liabilities |  |  | 7,614,657 |  |  |  | 8,675,167 |  |  |
Subsidiary obligation in excess of investment |  |  |  |  |  |  |  |  |  |
Investment in AE Advanced Fuels, Inc. |  |  | 31,324,660 |  |  |  | 8,400,675 |  |  |
Investment in Aemetis Americas, Inc |  |  | 246,676 |  |  |  | - |  |  |
Investment in Aemetis Biofuels, Inc. |  |  | 2,741,279 |  |  |  | 2,624,575 |  |  |
Investment in Aemetis Technologies, Inc. |  |  | 833,318 |  |  |  | 438,375 |  |  |
Investment in Biofuels Marketing, Inc. |  |  | 349,056 |  |  |  | 349,056 |  |  |
Total subsidiary obligation in excess of investment |  |  | 35,494,989 |  |  |  | 11,812,681 |  |  |
Total long term liabilities |  |  | 35,494,989 |  |  |  | 11,812,681 |  |  |
Stockholders' equity(deficit) |  |  |  |  |  |  |  |  |  |
Series B Preferred convertible stock |  |  | 2,401 |  |  |  | 3,098 |  |  |
Common stock |  |  | 199,737 |  |  |  | 180,281 |  |  |
Additional paid-in capital |  |  | 84,192,552 |  |  |  | 75,457,760 |  |  |
Accumulated deficit |  |  | (94,245,503 | ) |  |  | (69,808,294 | ) |  | )
Accumulated other comprehensive loss |  |  | (2,916,336 | ) |  |  | (2,317,893 | ) |  | )
Total stockholders' equity(deficit) |  |  | (12,767,149 | ) |  |  | 3,514,952 |  |  | )
Total liabilities & stockholders' equity(deficit) |  | $ | 30,342,497 |  |  | $ | 24,002,800 |  |  |
Schedule Parent Statements of Operations and Comprehensive Loss | Aemetis, Inc. (Parent Company) Consolidated Statements of Operations and Comprehensive Loss For the Years Ended December 31, 2013 and 2012
|  |  |  | 2013 |  | 2012
Equity in subsidiary losses |  |  | $ (22,134,091) |  | $ (12,496)
Selling, general and administrative expenses |  | 2,686,828 |  | 2,302,944
Operating loss |  |  |  | (24,820,919) |  | (2,315,440)
Other income/(expense) |  |  |  |  |
| Interest expense |  | (187,417) |  | (1,865,803)
| Other income/(expense) |  | 576,892 |  | (97,022)
Loss before income taxes |  |  | (24,431,444) |  | (4,278,265)
| Income taxes expense |  | (5,765) |  | (4,000)
Net loss |  |  |  | $ (24,437,209) |  | $ (4,282,265)
Other comprehensive loss |  |  |  |  |
| Foreign currency translation adjustment | (598,443) |  | (74,531)
Comprehensive loss |  |  | $ (25,035,652) |  | $ (4,356,796)
Parent Statements of Cash Flows | Aemetis, Inc. (Parent Company) Consolidated Statements of Cash Flows For the years ended December 31, 2013 and 2012
|  | 2013 |  |  | 2012 |
Operating activities: |  |  |  |  |  |
Net loss |  |  | (24,437,209 | ) |  |  | (4,282,265 | )
Adjustments to reconcile net loss to |  |  |  |  |  |  |  |
net cash provided/(used) in operating activities: |  |  |  |  |  |  |  |
Stock-based compensation |  |  | 1,760,072 |  |  |  | 686,059 |
Amortization of debt issuance discount |  |  | - |  |  |  | 400,997 |
Change in fair value of warrant liability |  |  | (197,127 | ) |  |  | 97,022 |
Changes in assets and liabilities: |  |  |  |  |  |  |  |
Subsidiary portion of net losses |  |  | 22,134,091 |  |  |  | 12,496 |
Prepaid expenses |  |  | - |  |  |  | 4,668 |
Accounts payable |  |  | (639,843 | ) |  |  | 236,887 |
Accrued interest expense |  |  | - |  |  |  | 682,983 |
Other liabilities |  |  | (177,896 | ) |  |  | 288,203 |
Net cash used in operating activities |  |  | (1,557,912 | ) |  |  | (1,872,950 | )
Investing activities: |  |  |  |  |  |  |  |
Change in outstanding checks in excess of cash |  |  | (25,773 | ) |  |  | 25,773 |
Subsidiary advances, net |  |  | 514,668 |  |  |  | 9,417,256 |
Net cash provided in investing activities |  |  | 488,895 |  |  |  | 9,443,029 |
Financing activities: |  |  |  |  |  |  |  |
Proceeds from borrowings under secured debt facilities |  |  | - |  |  |  | 840,000 |
Repayments of borrowings under secured debt facilities |  |  | - |  |  |  | (8,412,259 | )
Equity Offering |  |  | 1,075,200 |  |  |  | - |
Warrants exercised |  |  | 7,535 |  |  |  | 1,433 |
Net cash provided by/(used in)by financing activities |  |  | 1,082,735 |  |  |  | (7,570,826 | )
Net increase/(decrease) in cash and cash equivalents |  |  | 13,718 |  |  |  | (747 | )
Cash and cash equivalents at beginning of period |  |  | - |  |  |  | 747 |
Cash and cash equivalents at end of period |  | $ | 13,718 |  |  | $ | - |
Supplemental disclosures of cash flow information, cash paid: |  |  |  |  |  |  |  |
Interest payments |  |  | 4,522,097 |  |  |  | 2,084,751 |
Income tax expense |  |  | 5,765 |  |  |  | 4,000 |
Supplemental disclosures of cash flow information, non-cash transactions: |  |  |  |  |
Issuance of warrants to non-employees to secure procurement and working capital |  |  | 335,617 |  |  |  |  |
Issuance of warrants to subordinated debt holders |  |  | 1,127,120 |  |  |  |  |
Issuance of shares for acquisition |  |  | - |  |  |  | 12,511,200 |
Payments of principal, fees and interest by issuance of stock |  |  | 3,616,284 |  |  |  | 11,885,579 |
Issuance of shares to related party for repayment of line of credit |  |  | 821,946 |  |  |  | 4,107,141 |
Beneficial conversion discount on related party debt |  |  | - |  |  |  | 884,851 |
Other asset transferred to related party |  |  | 170,000 |  |  |  |  |
Warrant liability transferred to equity upon exercise |  |  | 1,006,648 |  |  |  |  |

X
- Definition No authoritative reference available. + References No definition available. + Details
Name: | AMTX_ParentBalanceSheetsTableTextblock
Namespace Prefix: | AMTX_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition No authoritative reference available. + References No definition available. + Details
Name: | AMTX_ParentStatementsOfCashFlowsTableTextblock
Namespace Prefix: | AMTX_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition No authoritative reference available. + References No definition available. + Details
Name: | AMTX_ScheduleParentStatementsOfOperationsAndComprehensiveLossTableTextBlock
Namespace Prefix: | AMTX_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration